These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2785004)

  • 1. Complement activation from protamine sulfate administration after coronary angiography.
    Click RL; Homburger HA; Bove AA
    Cathet Cardiovasc Diagn; 1989 Apr; 16(4):221-5. PubMed ID: 2785004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin.
    Morel DR; Zapol WM; Thomas SJ; Kitain EM; Robinson DR; Moss J; Chenoweth DE; Lowenstein E
    Anesthesiology; 1987 May; 66(5):597-604. PubMed ID: 3495208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
    Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration.
    Chiu RC; Samson R
    Ann Thorac Surg; 1984 Mar; 37(3):229-32. PubMed ID: 6703805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H; Ohkohchi K; Tagami H
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
    Westaby S; Dawson P; Turner MW; Pridie RB
    Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
    Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
    J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K; Takematsu H; Tagami H
    Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation and anaphylactoid response to protamine in a child after cardiopulmonary bypass.
    Westaby S; Turner MW; Stark J
    Br Heart J; 1985 May; 53(5):574-6. PubMed ID: 3994875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
    Ohkohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxin formation in extracorporeal circuits.
    Chenoweth DE
    Complement; 1986; 3(3):152-65. PubMed ID: 3492330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical pathway activation during an adverse response to protamine sulphate.
    Best N; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1983 Nov; 55(11):1149-53. PubMed ID: 6605758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.